| |
|
|
|
Cytosorbents Corporation  
|
|
4.59 0.01 (0%) |
10-16 16:00 |
|
Open: |
4.55 |
Pre close: |
4.58 |
Target:
|
6.11
|
|
High: |
4.645 |
Low: |
4.53 |
Resistance:
|
5.23
5.84
|
|
Volume: |
60,496 |
Market Cap: |
148M |
Support:
|
4.25
3.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.51
 |
MACD |
MACD(12,26):
|
-0.19 |
|
MA(20): |
4.93  |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
5.83 |
Stochastic Oscillator |
%K(14,3):
|
25.19 |
|
MA(250): |
7.25 |
%D(3): |
20.81 |
|
Average Volume(K) |
3-Month: |
18625
|
52-Week |
High:
|
12.00 |
|
10-Days: |
14431 |
Low: |
3.68 |
|
RSI |
RSI(14):
|
43.36 |
Change(%): |
-58.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.529 |
Return on Equity (ttm) |
-101.7 |
Shares Out. (M) |
32.30 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-32.0 |
Shares Float (M) |
26.48 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.20 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
8.3 |
% Held by Institutions |
27.15 |
|
Forward EPS |
-0.120 |
Gross Profit (p.s.) |
0.465 |
Shares Short (K) |
2690 |
|
Book Value (p.s.) |
0.360 |
EBITDA (p.s.) |
-0.485 |
P/E |
-8.68 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
12.75 |
|
Profit Margin |
-72.43 |
Operating Cash Flow
(M) |
-12.77 |
P/S |
203091776.00 |
|
Operating Margin |
-69.73 |
Levered Free Cash Flow
(M) |
-6.58 |
P/CF |
-11.61 |
|
|
|
|
|
|
